Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
| Strategy: | Combo: DNA & protein vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Mouse |
| Stage: | Assays Completed |
| Study Start Date: | 2010-02-09 |
| Study Made Public: | 2011-08-16 |
Title
Directing the immune response to well-defined HIV-1 envelope epitopes using the mucosal adjuvant Cholera toxin B as carrier
Description
CAVD 330 is an immunogenicity study evaluating the directing of the immune response to well-defined HIV-1 envelope epitopes using the mucosal adjuvant Cholera toxin B as carrier.
Sign in to see full information about this study and to download study data.